Cel Sci Corporation (CVM)

[GD]

Is CVM going to pull a trick on us like what NWBO has done:

NWBO trick:

SNO: Submit a final Late-Breaking abstract (with updated data) by September 1, 2020. If an updated abstract is not submitted by that date, the abstract will be automatically rejected.

DCVax-L Phase 3 clinical trial detailed results and analysis will be presented by Drs. Linda Liau & Marnix Bosch at the 2020 Society for Neuro-Oncology (SNO) on 11/20/2020:

https://www.eventscribe.com/2020/SNO/fsPopup.asp?efp=S0taQ1hBSFkxMTYzNQ&PresentationID=772799&rnd=0.2810788&query=Dcvax&mode=presinfo

If CVM is able to, CVM may submit the topline data as late-break to ESMO on Aug 17, and present the full data at ESMO, we will find out in two weeks
what is going on with CVM and ESMO, CVM and NWBO are in a race to report which company has the best immunotherapy for solid tumors, IMO.